These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 6143140)

  • 1. Focal osteomalacia due to low-dose diphosphonate therapy in Paget's disease.
    Boyce BF; Smith L; Fogelman I; Johnston E; Ralston S; Boyle IT
    Lancet; 1984 Apr; 1(8381):821-4. PubMed ID: 6143140
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Osteomalacia in a patient with Paget's bone disease treated with long-term etidronate.
    Hoppé E; Masson C; Laffitte A; Chappard D; Audran M
    Morphologie; 2012 Aug; 96(313):40-3. PubMed ID: 23022200
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Osteomalacia in Paget's disease treated with short term, high dose sodium etidronate.
    Gibbs CJ; Aaron JE; Peacock M
    Br Med J (Clin Res Ed); 1986 May; 292(6530):1227-9. PubMed ID: 3085789
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Spontaneous fractures in a patient treated with low doses of etidronic acid (disodium etidronate).
    Eyres KS; Marshall P; McCloskey E; Douglas DL; Kanis JA
    Drug Saf; 1992; 7(2):162-5. PubMed ID: 1605902
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pathologic fracture due to severe osteomalacia following low-dose diphosphonate treatment of Paget's disease of bone.
    Evans RA; Dunstan CR; Hills E; Wong SY
    Aust N Z J Med; 1983 Jun; 13(3):277-9. PubMed ID: 6416243
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The treatment of Paget's bone disease with sodium ethidronate.
    Fromm GA; Schajowicz F; Casco C; Ghiringhelli G; Mautalen CA
    Am J Med Sci; 1979; 277(1):29-37. PubMed ID: 106728
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Osteolysis, then fracture of the femur in a Paget's disease patient treated with high-dose disodium etidronate].
    Pinel B; Cambon C; Thomine JM; Cauvin M; Daragon A; Deshayes P
    Rev Rhum Mal Osteoartic; 1984; 51(7-8):417-8. PubMed ID: 6436959
    [No Abstract]   [Full Text] [Related]  

  • 8. Gross vertebral collapse associated with long-term disodium etidronate treatment for pelvic Paget's disease.
    MacGowan JR; Pringle J; Morris VH; Stamp TC
    Skeletal Radiol; 2000 May; 29(5):279-82. PubMed ID: 10883448
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Treatment of 10 cases of symptomatic Paget's disease with etidronate (EHDP)].
    Jung A; Mermillod B; Schenk R; Courvoisier B; Burkhardt P; Epiney J; Fleisch
    Schweiz Med Wochenschr; 1976 Nov; 106(48):1667-73. PubMed ID: 827810
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effective short term treatment of Paget's disease with oral etidronate.
    Preston CJ; Yates AJ; Beneton MN; Russell RG; Gray RE; Smith R; Kanis JA
    Br Med J (Clin Res Ed); 1986 Jan; 292(6513):79-80. PubMed ID: 3080099
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Paget's bone disease treated with diphosphonate and calcitonin.
    Hosking DJ; Bijvoet OL; van Aken J; Will EJ
    Lancet; 1976 Mar; 1(7960):615-7. PubMed ID: 55896
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Etidronate disodium in the treatment of Paget's disease of bone.
    Krane SM
    Ann Intern Med; 1982 May; 96(5):619-25. PubMed ID: 6280538
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multiple fractures in a woman receiving 24 years of etidronate treatment for Paget's disease.
    Labinson P; Taxel P
    Conn Med; 2007 May; 71(5):269-73. PubMed ID: 17526382
    [No Abstract]   [Full Text] [Related]  

  • 14. Effects of ethane-1 hydroxy-1, 1-diphosphonate (5 mg/kg/day dose) on quantitative bone histology in Paget's disease of bone.
    Alexandre C; Meunier PJ; Edouard C; Khairi RA; Johnston CC
    Metab Bone Dis Relat Res; 1981; 3(4-5):309-15. PubMed ID: 6820112
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative study of alendronate versus etidronate for the treatment of Paget's disease of bone.
    Siris E; Weinstein RS; Altman R; Conte JM; Favus M; Lombardi A; Lyles K; McIlwain H; Murphy WA; Reda C; Rude R; Seton M; Tiegs R; Thompson D; Tucci JR; Yates AJ; Zimering M
    J Clin Endocrinol Metab; 1996 Mar; 81(3):961-7. PubMed ID: 8772558
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Non-hormonal drug treatment in Paget's disease].
    Ryckewaert A; Lemaire V; Tubiana M
    Rev Rhum Mal Osteoartic; 1975 Nov; 42(11):693-8. PubMed ID: 131365
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Treatment of Paget's disease with diphosphonate (disodium ethydronate)].
    Caniggia A; Gennari C; Guideri R; Vattimo A; Nardi P
    Minerva Med; 1976 Jan; 67(1):1-15. PubMed ID: 814505
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Small doses of etidronate (EHDP) and Paget's disease: meaning and importance of the decrease in plasmatic 25(OH)D3.
    D'Amore M; Carrozzo M; Cantatore FP; Scagliusi P; Pipitone V
    Panminerva Med; 1984; 26(1):13-7. PubMed ID: 6233523
    [No Abstract]   [Full Text] [Related]  

  • 19. Beneficial effects of aminohexane diphosphonate in patients with Paget's disease of bone resistant to sodium etidronate.
    Delmas PD; Chapuy MC; Edouard C; Meunier PJ
    Am J Med; 1987 Aug; 83(2):276-82. PubMed ID: 3113247
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Treatment of Paget's disease of bone with ethane-1 hydroxy-1, 1 diphosphonate at low dosage (author's transl)].
    Alexandre C; Chapuy MC; Bressot C; Vignon E; Arlot M; Mathieu L; Edouard C; Johnston CC; Meunier PJ
    Nouv Presse Med; 1980 Nov; 9(45):3429-33. PubMed ID: 6777752
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.